Table I.
miRNA | Fold change (Treated/Untreated) | P-value | Chromosomal location |
---|---|---|---|
A, Upregulated
| |||
hsa-miR-6504-3p | 3.092 | 0.021 | 16 |
hsa-miR-4266 | 2.701 | 0.005 | 2q13 |
hsa-miR-4708-3p | 2.158 | 0.028 | 14 |
hsa-miR-532-5p | 2.055 | 0.039 | X |
hsa-miR-340-5p | 2.029 | 0.039 | 5 |
hsa-miR-203a-3p | 1.552 | 0.018 | 14 |
hsa-miR-1180-3p | 1.547 | 0.009 | 17 |
hsa-miR-146a-5p | 1.522 | 0.022 | 5 |
| |||
B, Downregulated
| |||
hsa-miR-6744-3p | 0.654 | 0.003 | 11 |
hsa-miR-6752-3p | 0.652 | 0.000 | 11 |
hsa-miR-6859-5p | 0.640 | 0.041 | |
hsa-miR-4669 | 0.636 | 0.030 | 9q34.2 |
hsa-miR-3607-5p | 0.526 | 0.045 | |
hsa-miR-604 | 0.445 | 0.011 | 10p11.23 |
Cells treated with aspirin that exhibited a fold change (FC)>1.5, FC<0.67, or a P-value <0.05 compared with untreated cells are presented.